ANIP 54.33 ANI Pharmaceuticals Inc $ANIP Hit a 52 week high

New Post Public Reply Private Reply Replies (0) Message Board

Nov 18, 2014 at 10:19 AM

ANIP 54.33 ANI Pharmaceuticals Inc $ANIP Hit a 52 week high of 54.32 Closing the day 09:44 at 54.33 +1.46 +2.76% With a day low of 52.94 and a total volume of 12,313.

ANIP Recent Posts: http://investorshangout.com/ANI-Pharmaceutica...NIP-53540/

ANIP ANI Pharmaceuticals Inc Recent Headline News

Amicus Therapeutics, Inc. (FOLD) in Focus: Stock Soars 17.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - 56 mins ago
Amicus Therapeutics, Inc. (FOLD) was a big mover last session, as the company saw its shares rise by nearly 18% on the day.
ANIP: 54.35 (+1.48), AMAG: 35.82 (+1.06), AFFX: 9.43 (+0.14), FOLD: 6.42 (-0.28)

Celldex Therapeutics, Inc. (CLDX) in Focus: Stock Soars 28.9% - Tale of the Tape
Vaishali Doshi Shah - Zacks Investment Research - 59 mins ago
Celldex Therapeutics, Inc. (CLDX) was a big mover last session, as the company saw its shares rise by almost 29% on the day.
ANIP: 54.35 (+1.48), CLDX: 17.48 (-0.77), AMAG: 35.82 (+1.06), AFFX: 9.43 (+0.14)

Integra (IART) Strengthens Spinal Implant with Twin Launches - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 17, 2:30PM CST
The latest Interbody and orthobiologic device launches are expected to drive a sequential increase in Integra Lifesciences' (IART) spine sales in the fourth quarter of 2014.
IART: 48.09 (+0.57), ANIP: 54.35 (+1.48), AMAG: 35.82 (+1.06), AFFX: 9.43 (+0.14)

Kite Pharma's Q3 Loss Narrows Y/Y, Focus on Pipeline - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 17, 9:42AM CST
Kite Pharma, Inc. (KITE) reported third-quarter 2014 loss of $0.24 per share well below the year-ago loss of $37 cents per share.
BIIB: 305.43 (+3.01), KITE: 40.34 (+0.04), ANIP: 54.35 (+1.48), AMAG: 35.82 (+1.06)

Puma Biotechnology Slumps: PBYI Tumbles 9.7% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 17, 7:45AM CST
Puma Biotechnology has been witnessing a negative trend in its current year loss estimates and its share price falling for past few weeks
ANIP: 54.35 (+1.48), AMAG: 35.82 (+1.06), AFFX: 9.43 (+0.14), PBYI: 216.59 (+5.04)

Affymetrix (AFFX) Now a Strong Buy, Raised Guidance Positive - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 5:13PM CST
On Nov 14, 2014, Zacks Investment Research upgraded Affymetrix Inc. (AFFX) to a Zacks Rank #1 (Strong Buy).
BIIB: 305.43 (+3.01), ANIP: 54.35 (+1.48), AMAG: 35.82 (+1.06), AFFX: 9.43 (+0.14)

Intercept Pharmaceuticals Slumps: ICPT Falls 5.9% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 7:34AM CST
Intercept Pharmaceuticals has been witnessing a negative trend in its current year earnings estimate and its share price has been falling for past few days
ANIP: 54.35 (+1.48), ICPT: 159.61 (+1.51), AMAG: 35.82 (+1.06), AFFX: 9.43 (+0.14)

Can the Rally in ANI Pharmaceuticals (ANIP) Shares Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 6:26AM CST
Can the Rally in ANI Pharmaceuticals (ANIP) Shares Continue?
ANIP: 54.35 (+1.48)

ANI Pharma (ANIP) & Sucampo Pharma (SCMP): Top Momentum Stocks to Add to Your Portfolio - Video Blog
David Bartosiak - Zacks Investment Research - Wed Nov 12, 1:59PM CST
ANI Pharma (ANIP) & Sucampo Pharma (SCMP), this week's top momentum stocks are discussed by Momentum Strategist David Bartosiak.
ANIP: 54.35 (+1.48), SCMP: 12.38 (+0.79)

Why ANI Pharmaceuticals (ANIP) Could Be Positioned for a Surge? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 7:54AM CST
ANI Pharmaceuticals could be an interesting play for investors because of its positive short-term momentum and solid earnings estimate revisions
ANIP: 54.35 (+1.48)

Celldex Falls with Pipeline Update Overshadowing Q3 Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 1:57PM CST
Celldex Therapeutics, Inc. (CLDX) amended the protocol for a pivotal study being conducted on glembatumumab vedotin for the treatment of triple negative breast cancer.
BIIB: 305.43 (+3.01), ANIP: 54.35 (+1.48), CLDX: 17.53 (-0.72), AMAG: 35.82 (+1.06)

Zacks Rank #1 Additions for Thursday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday
ALLY: 23.69 (+0.22), ANIP: 54.35 (+1.48), ACGL: 57.10 (+0.19), ACCO: 9.00 (+0.03), FLWS: 8.65 (+0.01)

ANI Pharmaceuticals Announces the Launch of Methazolamide Tablets USP
PR Newswire - Thu Nov 06, 7:30AM CST
ANI Pharmaceuticals, Inc. ("ANI"

(NASDAQ: ANIP) today announced the launch of Methazolamide USP 25mg and 50mg oral tablets, indicated for the treatment of ocular conditions. The US market for Methazolamide totals $24 million on a trailing 12 month basis, per IMS Health.
ANIP: 54.35 (+1.48)

Nasdaq stocks posting largest percentage increases
AP - Tue Nov 04, 12:22PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
SYKE: 23.43 (+0.32), HBNK: 20.13 (+0.07), ASMI: 41.92 (+0.21), RRGB: 68.05 (+0.60), SAPE: 24.68 (+0.03), PLUG: 3.97 (+0.25), ANIP: 54.35 (+1.48), ODP: 6.73 (+0.04), MTEX: 22.60 (+0.09), JAXB: 11.03 (-0.02), ALQA: 5.09 (+0.13), YRCW: 23.12 (+0.48)

Midday Gainers/ Losers
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 11:49AM CST

FRM: 6.34 (+0.22), NEO: 4.63 (+0.03), AU: 9.81 (+0.15), FNHC: 24.76 (+0.63), AMS: 2.53 (unch), NYMX: 0.53 (-0.01), AMDA: 1.33 (-0.02), CVD: 100.79 (+0.33), GBIM: 6.74 (+0.27), RCAP: 12.24 (+0.05), KBIO: 2.02 (+0.03), COOL: 0.75 (-0.01), SAPE: 24.68 (+0.03), XTLB: 2.43 (-0.15), GERN: 3.07 (+0.09), ANIP: 54.35 (+1.48), BBLU: 1.11 (-0.06), NXTD: 2.29 (+0.05), AP: 18.84 (+0.15), ALQA: 5.09 (+0.13)

ANI Pharma ups revenues 123% in Q3
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 8:21AM CST

ANIP: 54.35 (+1.48)

ANI posts 3Q profit
Automated Insights - Mon Nov 03, 7:46AM CST
BAUDETTE, Minn. (AP) _ ANI Pharmaceuticals Inc. (ANIP) on Monday reported profit of $6.7 million in its third quarter.
ANIP: 54.35 (+1.48)

ANI Pharmaceuticals beats by $0.20, beats on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 7:34AM CST

ANIP: 54.35 (+1.48)

ANI Pharmaceuticals Reports Record Third Quarter 2014 Financial Results and Year-To-Date Highlights
PR Newswire - Mon Nov 03, 7:30AM CST
ANI Pharmaceuticals, Inc. ("ANI"

(NASDAQ: ANIP) today reported financial results for the three and nine months ended September 30, 2014 and increased its revenue and non-GAAP EBITDA guidance for the fourth quarter of 2014.
ANIP: 54.35 (+1.48)

Notable earnings before Monday’s open
Seeking Alpha - at Seeking Alpha - Sun Nov 02, 4:30PM CST

ACW: 4.95 (+0.03), SYY: 38.92 (+0.03), L: 42.54 (-0.05), EEP: 38.47 (+0.24), SNH: 22.18 (unch), INN: 11.54 (+0.05), ITG: 19.97 (+0.43), NSP: 32.71 (+0.11), S: 4.80 (-0.11), ALE: 50.30 (+0.21), GVA: 36.05 (+0.34), MCY: 54.36 (+0.22), ARNA: 4.53 (+0.03), CHD: 73.96 (+0.07), ARE: 82.94 (unch), USAK: 18.75 (+0.31), BWP: 16.78 (-0.12), KRG: 26.20 (+0.02), CYOU: 22.55 (unch), MNKD: 6.45 (+0.19), HNT: 51.94 (+0.85), AMH: 17.30 (+0.04), ARCB: 42.20 (-0.13), ANIP: 54.35 (+1.48), AMG: 197.47 (+2.01), HAE: 37.34 (+0.34), SOHU: 49.68 (+0.45), CNA: 39.27 (+0.16)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Leidos' Autonomous Vessels Chart Bold Naval Waters

Leidos' Autonomous Leap with the U.S. Navy Well, today it's all about Leidos, an outfit that's been showing its grit in the world of maritime autonomy. Their systems aren't just tinkering around anymore—they're slicing through the waves at RIMPAC, the Rim of the Pacific, and running alongside the USS Theodore Roosevelt Carrier Strike Group. That's big news in anyone's...

How Timekettle Is Bridging Language Gaps at IFA 2026

Pioneering AI Innovations in Language Translation Timekettle is making some serious waves at IFA 2026, throwing its hat in the ring with innovations that redefine multilingual interaction. From sleek translation earbuds to full-blown meeting hubs, each gadget screams one thing loud and clear—communication sans language barriers. Centered in the tech extravaganza of...

BrightPlan's AI-Powered Growth: Series C Fuel

Series C Funding Ignites BrightPlan's Ambitions Ever seen a company that's ready to roll with the punches and come out stronger? That's BrightPlan for you. They're pushing the boundaries again, bagging new capital in this Series C round, steered by the seasoned folks over at ABS Capital Partners. Now, here's the thing: We're talking about a 230% revenue surge over just...

Spot the Signs: Early Gum Disease Insights from Experts

Why Early Detection of Gum Disease Matters Let's dive right into the crux of things. Gum disease, that sneaky antagonist of oral health, starts unassumingly. You brush, you floss, but those gums might still bleed—ever noticed? Dr. Marian Burgard of Fairport Family Dental has a thing or two to say about this, enlightening us through an insightful piece by HelloNation....

Tiger Group to Auction Huge Window Manufacturing Plant

Glass & Vinyl Ambitions: A New Chapter Who would have guessed? The seasoned window maker Showcase Window and Door Company is putting its prime manufacturing facility up for grabs. The online auction, orchestrated by Tiger Group, kicks off September 10, and it's sure to stir up some excitement in the industry. With picking up operations now within reach, it feels like...

MADD, Uber Rally at Capital Invitational for Safe Choices

Driving Change at the Capital Invitational Let's talk about a powerhouse collaboration aiming to do more than just thrill basketball fans. We're looking at MADD Sports, Uber, and the Capital Invitational joining forces at The St. James in Springfield, Virginia, on December 10, 2026. This is not your average sporting event; it's a gathering with a bigger purpose. The...

Jollibee and DreamWorks Unite for Cultural Celebration

Jollibee Partners with DreamWorks Animation Never thought I’d see the day: Jollibee, that familiar face of fast food, teaming up with the creative juggernaut DreamWorks Animation. They’re calling it a celebration of friendship and Filipino culture, wrapped up neatly in the context of a flick called Forgotten Island. Set to sizzle in theaters on September 25, 2026,...

Illinois' Legal Tangle: Feds Under Fire?

What a tangled web Illinois lawmakers have woven this time. They've gone and cooked up a pair of laws with a real knack for attracting attention—specifically from the folks over at the National Police Association (NPA). These aren’t your run-of-the-mill rules; they feel more like a blueprint for putting federal officers through the legal wringer and turning courtroom...

Alif Semiconductor Unveils StartKit for Edge AI MCU Fam

Here's some clarity amidst the storm of buzzwords: Alif Semiconductor has rolled out something the market's been howling for—Edge AI that doesn't break the bank. It's less about slick press releases and more about real-world implications. We're talking accessibility with their dirt-cheap, small-form-factor StartKit platform for Ensemble and Balletto microcontrollers....

Strategic Hire: Whisenhunt Joins FlexScreen & RiteScreen

Shaking Up the Window Screens Biz If you've been grinding in the window and door game, you know it's not an industry with a lot of buzz, but here comes a shot of caffeine. FlexScreen and RiteScreen just snagged David Whisenhunt to rev up their sales machine. Who's David Whisenhunt? Well, he's no rookie. With over two decades deep in the fenestration field, Whisenhunt...